Studies have documented effects on hair follicle function, renal function biomarkers, exercise capacity, and other parameters of tissue health that decline with age, providing evidence that senescent cell elimination through FOXO4-DRI can reverse some aspects of aging-related decline in research models
Reduction of triglyceride levels and very-low-density cholesterol were greatest with the 2.4 and 4.5 mg doses of cagrilintide, while changes from baseline of the other lipid and cholesterol levels were relatively similar across treatment groups [1]
It is the only GHRH analog approved for this indication
Eligible patients with commercial insurance may qualify for an Ozempic savings card
To minimize these, the dose is gradually increased over several months, and many patients notice their symptoms improve over time
This can lead to a smaller intake of essential daily nutrients in some cases